Abrocitinib

Chemical formula: C₁₄H₂₁N₅O₂S  Molecular mass: 323.42 g/mol  PubChem compound: 78323835

Therapeutic indications

Abrocitinib is indicated for:

Moderate-to-severe atopic dermatitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Abrocitinib is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Abrocitinib is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Severe hepatic impairment

Hepatic failure stage IV

Active serious systemic infections, including tuberculosis (TB)

at least one of
Systemic infection
Tuberculosis

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2024: CIBINQO Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈